Search Results

13,130 articles with title/keywords/abstract containing Lung cancer

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

Authors: Wang, Daoyuan; He, Jianxing

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 1-1(1)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Authors: Konopa, Krzysztof; Jassem, Jacek

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 2-11(10)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 12-28(17)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 29-36(8)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 37-47(11)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Predictive Markers for Haematological Toxicity of Pemetrexed

Authors: Kao, S. C.H.; Phan, V. H.; Clarke, S. J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 48-57(10)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Author: Tucker, Steven

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 58-60(3)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Authors: Ngeow, Joanne; Toh, Chee-Keong

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 61-66(6)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors: Wagner, Timothy D.; Yang, Gary Y.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 67-73(7)

Publisher: Bentham Science Publishers

Content loaded within last 14 days The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

Authors: Duruisseaux, Michael; Cadranel, Jacques; Perol, Maurice; Arpin, Dominique

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 74-77(4)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Author: Vincent, Mark

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 78-84(7)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Authors: Li, Tianhong; Lara Jr., Primo N.; Mack, Philip C.; Perez-Soler, Roman; Gandara, David R.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 85-94(10)

Publisher: Bentham Science Publishers

Content loaded within last 14 days Talaporfin sodium

Authors: Wang, S; Bromley, Elizabeth; Xu, Leon; Chen, James C; Keltner, Llew

Source: Expert Opinion on Pharmacotherapy, Volume 11, Number 1, January 2010 , pp. 133-140(8)

Publisher: Informa Healthcare

Content loaded within last 14 days Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma

Authors: Kuroda, Koji; Takenoyama, Mitsuhiro; Baba, Tetsuro; Shigematsu, Yoshiki; Shiota, Hironobu; Ichiki, Yoshinobu; Yasuda, Manabu; Uramoto, Hidetaka; Hanagiri, Takeshi; Yasumoto, Kosei

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 46-53(8)

Publisher: Blackwell Publishing

Content loaded within last 14 days Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Authors: Ozasa, Hiroaki; Oguri, Tetsuya; Uemura, Takehiro; Miyazaki, Mikinori; Maeno, Ken; Sato, Shigeki; Ueda, Ryuzo

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 161-166(6)

Publisher: Blackwell Publishing

Content loaded within last 14 days Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification

Authors: Yoshida, Takeshi; Okamoto, Isamu; Okamoto, Wataru; Hatashita, Erina; Yamada, Yuki; Kuwata, Kiyoko; Nishio, Kazuto; Fukuoka, Masahiro; Jänne, Pasi A.; Nakagawa, Kazuhiko

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 167-172(6)

Publisher: Blackwell Publishing

Content loaded within last 14 days Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model

Authors: Yang, Zhen-Zhou; Li, Meng-Xia; Zhang, Yun-Song; Xiang, De-Bing; Dai, Nan; Zeng, Lin-Li; Li, Zeng-Peng; Wang, Ge; Wang, Dong

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 180-187(8)

Publisher: Blackwell Publishing

Content loaded within last 14 days Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer

Authors: Yamada, Kazuhiko; Nakao, Masao; Fukuyama, Chikara; Nokihara, Hiroshi; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Ohe, Yuichiro; Ohki, Emiko; Hashimoto, Junichi; Tamura, Tomohide

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 188-195(8)

Publisher: Blackwell Publishing

Content loaded within last 14 days Updated treatment guidelines for stage IV NSCLC

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 2-2(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A